Nido Biosciences
Company

Nido Biosciences

Biotechnology Research The Fundamental Biology of Disease and Restore Healthy Cell Function. Nido-361 11 employees
Employees
11
Contacts
3
Emails
3
Phones
2

Nido Biosciences Overview

Headquarters
The Fundamental Biology of Disease and Restore Healthy Cell Function. Nido-361
Industry
Biotechnology Research
Employees
11
Founded
2018
Funding
86.6M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Nido Biosciences

Nido Bio is translating today’s neuroscience breakthroughs into tomorrow’s treatments for severe neurological diseases. Leveraging human genetics, we develop precision medicines that address the fundamental biology of disease and restore healthy cell function. NIDO-361, our clinical-stage candidate, is a treatment for Spinal and Bulbar Muscular Atrophy which is a rare and debilitating neuromuscular disease. Additional pipeline programs center around a novel target with the potential to address multiple disease mechanisms and that has broad clinical application across neurodegenerative and peripheral inflammatory diseases. We are creating a sustainable pipeline for the company by utilizing a functional genomics discovery platform based on human cell lines to identify novel targets. Through our approach we seek to transform patient lives in meaningful ways. www.nidobio.com.

Nido Biosciences Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
2
50.0% coverage

Nido Biosciences Org Chart

Sample employees and titles
Name Title Contact
Mike Clayman Independent Board Director
View
Marc Swikalus, Cpa, Mba Vice President Finance at Nido
Email
Jeremy P Springhorn, Phd Chief Executive Officer at Nido
Email Phone
Jamil M. Beg Venture Capitalist & Bioentrepreneur
Email Phone

Employees by Management Level

Executive 2 profiles
Director 1 profile
Individual contributor 1 profile

Compare Similar Companies to Nido Biosciences